Eva Verjans

632 total citations
20 papers, 420 citations indexed

About

Eva Verjans is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Eva Verjans has authored 20 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 6 papers in Immunology. Recurrent topics in Eva Verjans's work include Pulmonary Hypertension Research and Treatments (4 papers), Immune Response and Inflammation (3 papers) and Asthma and respiratory diseases (3 papers). Eva Verjans is often cited by papers focused on Pulmonary Hypertension Research and Treatments (4 papers), Immune Response and Inflammation (3 papers) and Asthma and respiratory diseases (3 papers). Eva Verjans collaborates with scholars based in Germany, United States and Belgium. Eva Verjans's co-authors include Christian Martin, Stefan Uhlig, Annette D. Rieg, Rolf Rossaint, Jürgen Bernhagen, Edgar Dahl, Anke K. Schütz, Arndt Hartmann, Nuran Bektas and Erik Noetzel and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Clinical Chemistry.

In The Last Decade

Eva Verjans

19 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Verjans Germany 12 171 113 110 47 46 20 420
Tingting Mills United States 14 103 0.6× 236 2.1× 128 1.2× 28 0.6× 24 0.5× 28 587
Gabriele Di Comite Italy 10 120 0.7× 92 0.8× 145 1.3× 24 0.5× 22 0.5× 21 404
Manabu Nagata Japan 11 81 0.5× 124 1.1× 107 1.0× 28 0.6× 29 0.6× 31 399
Claire Mackaaij Netherlands 8 212 1.2× 123 1.1× 81 0.7× 11 0.2× 38 0.8× 19 415
Zela Keuylian France 8 103 0.6× 124 1.1× 40 0.4× 20 0.4× 35 0.8× 10 364
Meei-Jyh Jiang Taiwan 10 75 0.4× 149 1.3× 43 0.4× 27 0.6× 28 0.6× 11 341
Azumi Hamasaki Japan 8 109 0.6× 139 1.2× 79 0.7× 14 0.3× 77 1.7× 56 385
Anouk Wezel Netherlands 18 427 2.5× 191 1.7× 48 0.4× 20 0.4× 68 1.5× 30 648
Jenni Virta Finland 12 58 0.3× 127 1.1× 68 0.6× 13 0.3× 71 1.5× 31 390

Countries citing papers authored by Eva Verjans

Since Specialization
Citations

This map shows the geographic impact of Eva Verjans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Verjans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Verjans more than expected).

Fields of papers citing papers by Eva Verjans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Verjans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Verjans. The network helps show where Eva Verjans may publish in the future.

Co-authorship network of co-authors of Eva Verjans

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Verjans. A scholar is included among the top collaborators of Eva Verjans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Verjans. Eva Verjans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seitz, Alexander, et al.. (2024). Epigenetic Leukocyte Counts from Dried Blood Spots of Pediatric Patients. Clinical Chemistry. 70(7). 997–999. 2 indexed citations
2.
Armann, Jakob, Uta Behrends, Reinhard Berner, et al.. (2023). Comparing SARS-CoV-2 variants among children and adolescents in Germany: relative risk of COVID-19-related hospitalization, ICU admission and mortality. Infection. 51(5). 1357–1367. 9 indexed citations
3.
Rieg, Annette D., Jan Spillner, Till Braunschweig, et al.. (2023). Amitriptyline inhibits bronchoconstriction and directly promotes dilatation of the airways. Respiratory Research. 24(1). 262–262. 2 indexed citations
4.
Ngo, Chuong, Lisa Lassay, Udo Kontny, et al.. (2023). Evaluation of lung function in a German single center cohort of young patients with sickle cell disease using EIT and standard techniques. Frontiers in Medicine. 10. 1100180–1100180. 1 indexed citations
5.
Rieg, Annette D., Eva Verjans, Jan Spillner, et al.. (2022). Platelet-derived growth factor (PDGF)-BB regulates the airway tone via activation of MAP2K, thromboxane, actin polymerisation and Ca2+-sensitisation. Respiratory Research. 23(1). 189–189. 5 indexed citations
6.
Armann, Jakob, Ulrich von Both, Markus Hufnagel, et al.. (2022). Association of SARS-CoV-2 Seropositivity With Myalgic Encephalomyelitis and/or Chronic Fatigue Syndrome Among Children and Adolescents in Germany. JAMA Network Open. 5(9). e2233454–e2233454. 6 indexed citations
7.
Rieg, Annette D., Eva Verjans, Jan Spillner, et al.. (2020). Levosimendan reduces segmental pulmonary vascular resistance in isolated perfused rat lungs and relaxes human pulmonary vessels. PLoS ONE. 15(5). e0233176–e0233176. 16 indexed citations
8.
Ngo, Chuong, Sylvia Lehmann, Eva Verjans, Klaus Tenbrock, & Steffen Leonhardt. (2020). Assessing global and regional pulmonary function with electrical impedance tomography in pediatric patients: the EIT-derived flow-volume loops. 1239–1239. 1 indexed citations
9.
Ziemann, Sebastian, Kim Ohl, Annette D. Rieg, et al.. (2019). Acid sphingomyelinase regulates TH2 cytokine release and bronchial asthma. Allergy. 75(3). 603–615. 14 indexed citations
10.
Ohl, Kim, Athanassios Fragoulis, Julian Baumeister, et al.. (2018). Nrf2 Is a Central Regulator of Metabolic Reprogramming of Myeloid-Derived Suppressor Cells in Steady State and Sepsis. Frontiers in Immunology. 9. 1552–1552. 46 indexed citations
11.
Verjans, Eva, Kim Ohl, Annette D. Rieg, et al.. (2018). Initiation of LPS-induced pulmonary dysfunction and its recovery occur independent of T cells. BMC Pulmonary Medicine. 18(1). 174–174. 25 indexed citations
12.
13.
Männ, Linda, Christian Martin, Eva Verjans, et al.. (2016). CD11c.DTR mice develop a fatal fulminant myocarditis after local or systemic treatment with diphtheria toxin. European Journal of Immunology. 46(8). 2028–2042. 14 indexed citations
14.
Verjans, Eva, Simone Schrading, H.-P. Berlien, et al.. (2015). Kaposiformes kongenitales Hämangioendotheliom als Geburtshindernis und postpartaler Notfall. Monatsschrift Kinderheilkunde. 164(4). 318–322.
15.
Verjans, Eva, Kim Ohl, Lucy Kathleen Reiss, et al.. (2015). The cAMP response element modulator (CREM) regulates TH2 mediated inflammation. Oncotarget. 6(36). 38538–38551. 14 indexed citations
16.
Rieg, Annette D., Alberto Pérez-Bouza, Till Braunschweig, et al.. (2014). Milrinone Relaxes Pulmonary Veins in Guinea Pigs and Humans. PLoS ONE. 9(1). e87685–e87685. 26 indexed citations
17.
Rieg, Annette D., et al.. (2013). Levosimendan Relaxes Pulmonary Arteries and Veins in Precision-Cut Lung Slices - The Role of KATP-Channels, cAMP and cGMP. PLoS ONE. 8(6). e66195–e66195. 26 indexed citations
18.
Verjans, Eva, Kim Ohl, Yu Yin, et al.. (2013). Overexpression of CREMα in T Cells Aggravates Lipopolysaccharide-Induced Acute Lung Injury. The Journal of Immunology. 191(3). 1316–1323. 21 indexed citations
19.
Verjans, Eva, Erik Noetzel, Nuran Bektas, et al.. (2009). Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer. BMC Cancer. 9(1). 230–230. 115 indexed citations
20.
Verjans, Eva, et al.. (1983). Clinical parameters and intrathecal IgG synthesis as prognostic features in multiple sclerosis. Part I. Journal of Neurology. 229(3). 155–165. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tingting Mills Breakdown of academic impact, for papers by Gabriele Di Comite Breakdown of academic impact, for papers by Manabu Nagata Breakdown of academic impact, for papers by Claire Mackaaij Breakdown of academic impact, for papers by Zela Keuylian Breakdown of academic impact, for papers by Meei-Jyh Jiang Breakdown of academic impact, for papers by Azumi Hamasaki Breakdown of academic impact, for papers by Anouk Wezel Breakdown of academic impact, for papers by Jenni Virta
Rankless by CCL
2026